Danni Ran

1.6k total citations
16 papers, 1.4k citations indexed

About

Danni Ran is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Danni Ran has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Biomedical Engineering and 9 papers in Biomaterials. Recurrent topics in Danni Ran's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (8 papers) and Nanoplatforms for cancer theranostics (7 papers). Danni Ran is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (8 papers) and Nanoplatforms for cancer theranostics (7 papers). Danni Ran collaborates with scholars based in China, United States and Belgium. Danni Ran's co-authors include Weiyue Lu, Liangfang Zhang, Ronnie H. Fang, Changyou Zhan, Xiaoli Wei, Cao Xie, Zhilan Chai, Huitong Ruan, Linwei Lu and Kuan Jiang and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Danni Ran

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danni Ran China	15	759	715	641	140	126	16	1.4k
Randall Toy United States	16	779 1.0×	429 0.6×	757 1.2×	216 1.5×	23 0.2×	22	1.6k
Jessica Ngai United States	8	1.0k 1.4×	699 1.0×	911 1.4×	224 1.6×	32 0.3×	11	1.8k
Zachary P. Lin Canada	11	1.4k 1.8×	858 1.2×	1.2k 1.9×	283 2.0×	41 0.3×	15	2.3k
Netra U. Rajesh United States	3	832 1.1×	501 0.7×	696 1.1×	161 1.1×	26 0.2×	5	1.3k
Blaine J. Zern United States	16	463 0.6×	487 0.7×	580 0.9×	130 0.9×	18 0.1×	19	1.4k
Amir K. Varkouhi Netherlands	12	498 0.7×	1.4k 1.9×	592 0.9×	175 1.3×	11 0.1×	17	2.0k
Dafeng Chu China	13	717 0.9×	534 0.7×	403 0.6×	442 3.2×	44 0.3×	16	1.3k
Yi‐Yin Tai United States	8	889 1.2×	725 1.0×	530 0.8×	397 2.8×	20 0.2×	16	1.5k
Jeremy Rothschild Canada	4	824 1.1×	502 0.7×	694 1.1×	155 1.1×	28 0.2×	7	1.3k
Prakash Rai United States	14	971 1.3×	626 0.9×	729 1.1×	118 0.8×	14 0.1×	30	1.8k

Countries citing papers authored by Danni Ran

Since Specialization

Citations

This map shows the geographic impact of Danni Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danni Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danni Ran more than expected).

Fields of papers citing papers by Danni Ran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danni Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danni Ran. The network helps show where Danni Ran may publish in the future.

Co-authorship network of co-authors of Danni Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Danni Ran. A scholar is included among the top collaborators of Danni Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danni Ran. Danni Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lu, Linwei, Jianfen Zhou, Danni Ran, et al.. (2022). All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals. Journal of Controlled Release. 345. 685–695. 33 indexed citations

Ran, Danni, Jianfen Zhou, Zhilan Chai, et al.. (2020). All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide. Theranostics. 10(9). 4073–4087. 32 indexed citations

Li, Jinyang, Zhilan Chai, Jiasheng Lu, et al.. (2020). ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy. Journal of Controlled Release. 322. 542–554. 16 indexed citations

Wang, Xiaoyi, Nana Meng, Songli Wang, et al.. (2019). Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes. Journal of Controlled Release. 316. 381–392. 43 indexed citations

Chai, Zhilan, Danni Ran, Linwei Lu, et al.. (2019). Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma. ACS Nano. 13(5). 5591–5601. 303 indexed citations

Wei, Xiaoli, Mara Beltrán‐Gastélum, Emil Karshalev, et al.. (2019). Biomimetic Micromotor Enables Active Delivery of Antigens for Oral Vaccination. Nano Letters. 19(3). 1914–1921. 170 indexed citations

Wei, Xiaoli, Danni Ran, Anaamika Campeau, et al.. (2019). Multiantigenic Nanotoxoids for Antivirulence Vaccination against Antibiotic-Resistant Gram-Negative Bacteria. Nano Letters. 19(7). 4760–4769. 77 indexed citations

Man, Ying, Songli Wang, Mingfei Zhang, et al.. (2018). Myristic Acid-Modified ^DA7R Peptide for Whole-Process Glioma-Targeted Drug Delivery. ACS Applied Materials & Interfaces. 10(23). 19473–19482. 26 indexed citations

Wei, Xiaoli, Gang Zhang, Danni Ran, et al.. (2018). T‐Cell‐Mimicking Nanoparticles Can Neutralize HIV Infectivity. Advanced Materials. 30(45). e1802233–e1802233. 173 indexed citations

10.

Chai, Zhilan, Xuefeng Hu, Xiaoli Wei, et al.. (2017). A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. Journal of Controlled Release. 264. 102–111. 215 indexed citations

11.

Ran, Danni, Changyou Zhan, Cao Xie, et al.. (2017). d-Retroenantiomer of Quorum-Sensing Peptide-Modified Polymeric Micelles for Brain Tumor-Targeted Drug Delivery. ACS Applied Materials & Interfaces. 9(31). 25672–25682. 39 indexed citations

12.

Ran, Danni, Qing Shen, Cao Xie, et al.. (2017). GRP78 enabled micelle-based glioma targeted drug delivery. Journal of Controlled Release. 255. 120–131. 65 indexed citations

13.

Ran, Danni, et al.. (2017). EGFR/EGFRvIII Dual-Targeting Peptide-Mediated Drug Delivery for Enhanced Glioma Therapy. ACS Applied Materials & Interfaces. 9(29). 24462–24475. 56 indexed citations

14.

Wei, Xiaoli, Jie Gao, Changyou Zhan, et al.. (2015). Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Journal of Controlled Release. 218. 13–21. 120 indexed citations

15.

Guo, Jialiang, et al.. (2015). One-pot preparation of a sulfamethoxazole functionalized affinity monolithic column for selective isolation and purification of trypsin. Journal of Chromatography A. 1400. 47–53. 8 indexed citations

16.

Guo, Jialiang, Qiaoxuan Zhang, Zhe Yao, et al.. (2014). One‐step strategy for the synthesis of a derivatized cyclodextrin‐based monolithic column. Journal of Separation Science. 37(14). 1720–1727. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact